Zaher Nahle

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: Solve ME/CFS Initiative

Zaher Nahle, PhD, MPA, is an award-winning scientist with interdisciplinary training in administration and biomedical research. He is the Executive Director of the Arthritis National Research Foundation (ANRF, known as*. ANRF stands among the top 1% of US Charities and is dedicated to funding innovative research to understand the causes of osteoarthritis, rheumatoid arthritis, lupus, juvenile arthritis, Fibromyalgia and related autoimmune and inflammatory conditions.

From June 2015 to February 2018, Dr. Nahle served as Chief Scientific Officer (CSO) and Vice President for Research at Solve ME/CFS Initiative (SMCI)[1] where he oversaw a research and scientific portfolio that included a peer-review grant program for external investigators, specialized biobanking and patient registry platforms as well as numerous medical education initiatives for patients and healthcare professionals. He also directed a specialized investment program with medical centers, government agencies and industry partners to spark innovation and accelerate the discovery process in the ME/CFS disease space.

Dr. Nahle is a frequent speaker at international conferences and serves on specialized committees at federal agencies, including the NIH and the CDC. His background spans the fields of cancer biology, high-throughput technologies, diabetes, and ME/CFS. Prior to joining SMCI, he served on the faculty at leading universities, including as an Assistant Professor of Neurosurgery and Cancer Biology at Vanderbilt University Medical Center[2], and founded a nonprofit organization focused on the disability agenda with a classmate while at Harvard. His work is featured in journals like Science and Nature. He was an awardee of the American Heart Association (AHA) and the Department of Defense (DoD) and a Mason fellow at Harvard. He received a PhD in Physiology and Biophysics from Cold Spring Harbor Laboratory/Stony Brook and an MPA from Harvard University, where he also completed a fellowship in public policy and management at the John F. Kennedy School of Government.

Education[edit | edit source]

  • Master in Public Administration from Harvard University’s John F. Kennedy School of Government (2013)
  • PhD in physiology and biophysics from Cold Spring Harbor Laboratory and Stony Brook University (2003)
  • Post-doctoral fellowships at both Harvard and StonyBrook (2003-04)
  • Bachelor's degree in Chemistry from American University of Beirut (1995)

Awards[edit | edit source]

  • Robert Wood Johnson Foundation PEER White Label Award - for the establishment and implementation of a national Patient Registry and Electronic Health Information (EHI) system for ME/CFS (2016) [3]
  • Harvard Kennedy School, Merit Scholarship (2013)
  • American Cancer Society (ACS) Scholar (pay if) - Outstanding score (2011)
  • National Priorities Research Program - Qatar Foundation (2010)
  • American Heart Association (AHA) career development award BGIA - Outstanding score (2008)
  • Department of Defense Breast Cancer Fellowship Award - Congressionally Directed Medical Research Programs (2000)

National committees and advocacy[edit | edit source]

Interviews & Talks[edit | edit source]

Open Letter to The Lancet[edit | edit source]

Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Nahle, along with 41 colleagues in the ME/CFS field, signed the second letter.

Blog Posts and Editorials (selected)[edit | edit source]





Online presence[edit | edit source]

References[edit | edit source]

The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history